Overview

Pediatric Respiratory Medicine

Volumn , Issue , 2008, Pages 845-857

  Anselmo, Mark A ^a,b   Lands, Larry C ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882543859     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032304048-8.50064-5     Document Type: Chapter

References (159)

1. AM Comeau, et al. (2004) Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: A cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics 113 1573-1581.
2. Cystic Fibrosis Foundation: Patient Registry 2004 Annual Report. Bethesda, Maryland.
3. PM Quinton (1999) Physiological basis of cystic fibrosis: A historical perspective. Physiol Rev 79 S3-S22.
4. BJ Rosenstein and GR Cutting (1998) The diagnosis of cystic fibrosis: A consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132 589-595.
5. SM Rowe, S Miller and EJ Sorscher (2005) Cystic fibrosis. N Engl J Med 352 1992-2001.
6. JR Yankaskas, BC Marshall, B Sufian, et al. (2004) Cystic fibrosis adult care: Consensus conference report. Chest 125 1S-39S.
7. Cystic Fibrosis Foundation (2005) Patient Registry 2004 Annual Report Bethesda: Maryland
8. MR Kosorok, et al. (1996) The incidence of cystic fibrosis. Stat Med 15 449-462.
9. MJ Welsh, et al. (1995) In Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The metabolic and molecular Bases of inherited disease New York: McGraw-Hill
10. A Hamosh, et al. (1998) Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr 132 255-259.
11. JR Riordan, et al. (1989) Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245 1066-1073.
12. K Kunzelmann, et al. (2000) Control of epithelial Na+ conductance by the cystic fibrosis transmembrane conductance regulator. Pflugers Arch 440 193-201.
13. DF McAuley, et al. (2000) Cystic fibrosis: Basic science. Paediatr Respir Rev 1 93-100.
14. SM Rowe, et al. (2005) Cystic fibrosis. N Engl J Med 352 1992-2001.
15. Cystic Fibrosis Mutation Database. http://www.genet.sickkids.on.ca/cftr/
16. JL Bobadilla, et al. (2002) Cystic fibrosis: A worldwide analysis of CFTR mutations—correlation with incidence data and application to screening. Hum Mutat 19 575-606.
17. M Mall, et al. (2004) Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10 487-493.
18. Cystic Fibrosis Foundation. Patient Registry 2001 Annual Report. 2002. Bethesda, Maryland.
19. C Wiuf (2001) Do delta F508 heterozygotes have a selective advantage? Genet Res 78 41-47.
20. DE Reich, et al. (2001) On the allelic spectrum of human disease. Trends Genet 17 502-510.
21. R Busch (1990) On the history of cystic fibrosis. Acta Univ Carol [Med] (Praha) 36 13-15.
22. Alonso y de los Ruyes de Fonteca J: Diez Previlegios para Mgeres Preñadas. Alcalá de Henares 212, 1606.
23. F Liszt (1877) Life of Chopin London: William Reevers 28-66. (translated by John Broadhouse)
24. AK Kubba, et al. (1998) The long suffering of Frederic Chopin. Chest 113 210-216.
25. Rietschel ET, et al: How the mighty have fallen: Fatal infectious diseases of divine composers. Infect Dis Clin North Am 18:311-339.
26. K Landsteiner (1905) Darmverschluss durch eingedicktes Meconium Pankreatitis. Centr Allg Pathol 16 903-907.
27. KD Blackfan, et al. (1933) Vitamin A deficiency in infants. J Paediatr 3 679-706.
28. Fanconi GE, et al: Das coeliakiesyndrom bei angeborener zysticher pankreasfibromatose und bronchiectasien. Wiener Klin Wochen 753, 1936.
29. DH Andersen (1938) Cystic fibrosis of the pancreas and its relation to celiac disease. Am J Dis Child 56 344-399.
30. S Farber (1945) Some organic digestive disturbances in early life. J Mich State Med Soc 44 587-594.
31. DH Andersen, et al. (1946) Celiac syndrome. V. Genetics of cystic fibrosis of the pancreas with a consideration of the etiology. Am J Dis Child 62-80.
32. PA Di Sant'Agnese, et al. (1953) Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas: Clinical significance and relationship to the disease. Pediatrics 12 549-563.
33. LE Gibson, et al. (1959) A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23 545-549.
34. M Knowles, et al. (1981) Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 305 1489-1495.
35. PM Quinton (1983) Chloride impermeability in cystic fibrosis. Nature 301 421-422.
36. PM Quinton (1999) Physiological basis of cystic fibrosis: A historical perspective. Physiol Rev 79 S3-S22.
37. M Szaff, et al. (1983) Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand 72 651-657.
38. J Scott, et al. (1988) Heart-lung transplantation for cystic fibrosis. Lancet 2 192-194.
39. H Eiberg, et al. (1985) Linkage relationships of paraoxonase (PON) with other markers: Indication of PON-cystic fibrosis synteny. Clin Genet 28 265-271.
40. RG Knowlton, et al. (1985) A polymorphic DNA marker linked to cystic fibrosis is located on chromosome 7. Nature 318 380-382.
41. LC Tsui, et al. (1985) Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science 230 1054-1057.
42. BJ Wainwright, et al. (1985) Localization of cystic fibrosis locus to human chromosome 7cen-q22. Nature 318 384-385.
43. B Kerem, et al. (1989) Identification of the cystic fibrosis gene: Genetic analysis. Science 245 1073-1080.
44. JM Rommens, et al. (1989) Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245 1059-1065.
45. The Cystic Fibrosis Genotype-Phenotype Consortium (1993) Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 329 1308-1313.
46. G Doring, et al. (1994) Allotypes of alpha 1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508. Pediatr Pulmonol 18 3-7.
47. R Mahadeva, et al. (2001) Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis. Thorax 56 53-58.
48. P Garred, et al. (1999) Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 104 431-437.
49. ML Drumm, et al. (2005) Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353 1443-1453.
50. T Lamireau, et al. (2004) Epidemiology of liver disease in cystic fibrosis: A longitudinal study. J Hepatol 41 920-925.
51. KA Lindenmuth, et al. (1989) Advanced xerophthalmia as a presenting sign in cystic fibrosis. Ann Ophthalmol 21 189-191.
52. RS Abernathy (1976) Bulging fontanelle as presenting sign in cystic fibrosis. Vitamin A metabolism and effect on cerebrospinal fluid pressure. Am J Dis Child 130 1360-1362.
53. PC ter Avest, et al. (2005) [Haemolytic anaemia and a clotting disorder as first signs of cystic fibrosis in two infants]. Ned Tijdschr Geneeskd 149 2125-2128.
54. M Beauchamp, et al. (2005) Sweat-testing: a review of current technical requirements. Pediatr Pulmonol 39 507-511.
55. BJ Rosenstein, et al. (1998) The diagnosis of cystic fibrosis: A consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132 589-595.
56. MW Leigh (2004) Diagnosis of CF despite normal or borderline sweat chloride. Paediatr Respir Rev 5(Suppl A), S357-S359.
57. PM Farrell, et al. (1996) Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis. Pediatrics 97 524-528.
58. AM Comeau, et al. (2004) Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: A cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics 113 1573-1581.
59. PG Noone, et al. (2000) Lung disease associated with the IVS8 5T allele of the CFTR gene. Am J Respir Crit Care Med 162 1919-1924.
60. JE Dankert-Roelse, et al. (1987) Effect of screening for cystic fibrosis on the influence of genetic counseling. Clin Genet 32 271-275.
61. T Dudding, et al. (2000) Reproductive decisions after neonatal screening identifies cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 82 F124-F127.
62. Genetic testing for cystic fibrosis (1999) National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis. Arch Intern Med 159 1529-1539.
63. American College of Obstetricians and Gynecologists, A. C. O. M. G: Preconception and prenatal carrier screening for cystic fibrosis. Clinical and laboratory guidelines. Washington, DC, 2001.
64. MS Watson, et al. (2004) Cystic fibrosis population carrier screening: 2004 Revision of American College of Medical Genetics mutation panel. Genet Med 6 387-391.
65. RG Gregg, et al. (1993) Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): Comparison of screening protocols. Am J Hum Genet 52 616-626.
66. G Romeo, et al. (1989) Why is the cystic fibrosis gene so frequent? Hum Genet 84 1-5.
67. RJ Massie, et al. (2005) Screening couples for cystic fibrosis carrier status: Why are we waiting? Med J Aust 183 501-502.
68. A Dupuis, et al. (2005) Cystic fibrosis birth rates in Canada: A decreasing trend since the onset of genetic testing. J Pediatr 147 312-315.
69. V Scotet, et al. (2003) Impact of public health strategies on the birth prevalence of cystic fibrosis in Brittany, France. Hum Genet 113 280-285.
70. N Simpson, et al. (2005) The cost-effectiveness of neonatal screening for cystic fibrosis: An analysis of alternative scenarios using a decision model. Cost Eff Resour Alloc 3 8.
71. MI Evans, et al. (2005) Invasive prenatal diagnostic procedures 2005. Semin Perinatol 29 215-218.
72. Canadian Cystic Fibrosis Foundation. Canadian Patient Data Registry, National Report, 2000. Toronto, 2001.
73. FJ Accurso, et al. (2005) Complications associated with symptomatic diagnosis in infants with cystic fibrosis. J Pediatr 147 S37-S41.
74. PM Farrell, et al. (2001) Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics 107 1-13.
75. RL Koscik, et al. (2004) Cognitive function of children with cystic fibrosis: Deleterious effect of early malnutrition. Pediatrics 113 1549-1558.
76. HJ Lai, et al. (2005) The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: Evidence from the United States Cystic Fibrosis Foundation registry data. J Pediatr 147 S57-S63.
77. MK Sontag, et al. (2005) Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: Screening efficacy and diagnostic outcomes. J Pediatr 147 S83-S88.
78. MJ Rock, et al. (2005) Newborn screening for cystic fibrosis in Wisconsin: Nine-year experience with routine trypsinogen/DNA testing. J Pediatr 147 S73-S77.
79. A Tluczek, et al. (2005) Psychosocial risk associated with newborn screening for cystic fibrosis: Parents’ experience while awaiting the sweat-test appointment. Pediatrics 115 1692-1703.
80. SD Grosse, et al. (2004) Newborn screening for cystic fibrosis: Evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep 53 1-36.
81. D Borowitz, et al. (2004) Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis. J Pediatr 145 322-326.
82. T Stevens, et al. (2004) Analysis of pancreatic elastase-1 concentrations in duodenal aspirates from healthy subjects and patients with chronic pancreatitis. Dig Dis Sci 49 1405-1411.
83. D Borowitz, et al. (2004) Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis. J Pediatr 145 322-326.
84. E Kerem, et al. (2005) Standards of care for patients with cystic fibrosis: A European consensus. J Cyst Fibros 4 7-26.
85. JR Yankaskas, et al. (2004) Cystic fibrosis adult care: Consensus conference report. Chest 125 1S-39S.
86. JR Yankaskas, et al. (2004) Cystic fibrosis adult care: Consensus conference report. Chest 125 1S-39S.
87. A Moran (2000) Cystic fibrosis-related diabetes: An approach to diagnosis and management. Pediatr Diabetes 1 41-48.
88. S Lanng, et al. (1992) Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 151 684-687.
89. SM Finkelstein, et al. (1988) Diabetes mellitus associated with cystic fibrosis. J Pediatr 112 373-377.
90. CE Milla, et al. (2000) Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 162 891-895.
91. A Moran, et al. (1999) Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: A consensus conference report. Diabetes Res Clin Pract 45 61-73.
92. A Moran, et al. (1991) Pancreatic endocrine function in cystic fibrosis. J Pediatr 118 715-723.
93. C Koch, et al. (2001) European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 31 1-12.
94. A Iannucci, et al. (1984) Endocrine pancreas in cystic fibrosis: An immunohistochemical study. Hum Pathol 15 278-284.
95. K Soejima, et al. (1986) Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: Morphometric and immunocytologic studies. Pediatr Pathol 6 25-46.
96. B Yung, et al. (2002) Cystic fibrosis-related diabetes: The role of peripheral insulin resistance and beta-cell dysfunction. Diabet Med 19 221-226.
97. DS Hardin, et al. (2001) Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab 281 E1022-E1028.
98. S Lanng, et al. (1994) Diabetes mellitus in cystic fibrosis: Effect of insulin therapy on lung function and infections. Acta Paediatr 83 849-853.
99. EH Mischler, et al. (1979) Demineralization in cystic fibrosis detected by direct photon absorptiometry. Am J Dis Child 133 632-635.
100. TJ Hahn, et al. (1979) Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr 94 38-42.
101. LK Bachrach, et al. (1994) Osteopenia in adults with cystic fibrosis. Am J Med 96 27-34.
102. RM Aris, et al. (1998) Increased rate of fractures and severe kyphosis: Sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 128 186-193.
103. RC Henderson, et al. (1996) Bone density in children and adolescents with cystic fibrosis. J Pediatr 128 28-34.
104. RM Aris, et al. (2005) Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 90 1888-1896.
105. GI Baroncelli, et al. (1997) Bone demineralization in cystic fibrosis: Evidence of imbalance between bone formation and degradation. Pediatr Res 41 397-403.
106. RM Aris, et al. (1999) Altered calcium homeostasis in adults with cystic fibrosis. Osteoporos Int 10 102-108.
107. CS Haworth, et al. (1999) Low bone mineral density in adults with cystic fibrosis. Thorax 54 961-967.
108. RM Aris, et al. (2000) Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am J Respir Crit Care Med 162 1674-1678.
109. SL Elkin, et al. (2002) Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis. Am J Respir Crit Care Med 166 1470-1474.
110. RK Lark, et al. (2001) Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. Am J Clin Nutr 73 602-606.
111. SJ King, et al. (2005) Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor. Eur Respir J 25 54-61.
112. J Emerson, et al. (2002) Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 34 91-100.
113. N Hoiby, et al. (2005) Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 4 Suppl 2 49-54.
114. Z Li, et al. (2005) Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 293 581-588.
115. GR Graff, et al. (2002) Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis. Chest 121 1754-1760.
116. C Koch, et al. (2003) Patient cohorting and infection control. Semin Respir Crit Care Med 24 703-716.
117. K Tan, et al. (2002) Alcaligenes infection in cystic fibrosis. Pediatr Pulmonol 34 101-104.
118. JJ LiPuma (2003) Burkholderia and emerging pathogens in cystic fibrosis. Semin Respir Crit Care Med 24 681-692.
119. C Koch, et al. (2003) Patient cohorting and infection control. Semin Respir Crit Care Med 24 703-716.
120. JJ LiPuma (2003) Burkholderia and emerging pathogens in cystic fibrosis. Semin Respir Crit Care Med 24 681-692.
121. JH Yang, T Spilker and JJ LiPuma (2006) Simultaneous coinfection by multiple strains during Burkholderia cepacia complex infection in cystic fibrosis. Diagn Microbiol Infect Dis 54 95-98.
122. L Liu, et al. (2003) Identification by subtractive hybridization of a novel insertion element specific for two widespread Burkholderia cepacia genomovar III strains. J Clin Microbiol 41 2471-2476.
123. L Saiman, et al. (2003) Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Am J Infect Control 31 S1-S62.
124. TG Liou, et al. (2001) Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 153 345-352.
125. JJ LiPuma (2001) Burkholderia cepacia complex: A contraindication to lung transplantation in cystic fibrosis? Transpl Infect Dis 3 149-160.
126. TG Liou, et al. (2001) Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 153 345-352.
127. SA De, et al. (2001) Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358 1780-1781.
128. SA Chitty, et al. (2005) Mycobacterium avium complex pulmonary disease in immunocompetent patients. South Med J 98 646-652.
129. JO Falkinham, et al. (2001) Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems. Appl Environ Microbiol 67 1225-1231.
130. IS Kourbeti, et al. (2000) Nontuberculous mycobacterial infections of the lung. Curr Infect Dis Rep 2 193-200.
131. Medical Section of the American Lung Association (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Am J Respir Crit Care Med 156 S1-S25.
132. FC Bange, et al. (1999) Recovery of mycobacteria from patients with cystic fibrosis. J Clin Microbiol 37 3761-3763.
133. Diagnosis and treatment of disease caused by nontuberculous mycobacteria (1997) This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 156 S1-S25.
134. C Pierre-Audigier, et al. (2005) Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 43 3467-3470.
135. K Olivier, et al. (2003) Nontuberculous mycobacteria. I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 167 828-834.
136. AR Cullen, et al. (2000) Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection? Am J Respir Crit Care Med 161 641-645.
137. AA Colin (2000) Eradication of Mycobacterium abscessus in a chronically infected patient with cystic fibrosis. Pediatr Pulmonol 30 267-268.
138. MA Malouf, et al. (1999) The spectrum of mycobacterial infection after lung transplantation. Am J. Respir Crit Care Med 160 1611-1616.
139. RN Chernish, et al. (2003) Approach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosis. Curr Opin Pulm Med 9 509-515.
140. SD Aaron, et al. (2005) Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: A randomised, double-blind, controlled clinical trial. Lancet 366 463-471.
141. FW Abdul-Karim, et al. (1982) Carcinoma of extrahepatic biliary system in an adult with cystic fibrosis. Gastroenterology 82 758-762.
142. JC McIntosh, et al. (1988) Pancreatic adenocarcinoma in a patient with cystic fibrosis. Am J Med 85 592.
143. H Chaun, et al. (1996) Colonic carcinoma in two adult cystic fibrosis patients. Can J Gastroenterol 10 440-442.
144. JP Neglia, et al. (1995) The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 332 494-499.
145. MH Schoni, et al. (1996) Cancer risk in patients with cystic fibrosis: The European data. CF/CSG Group. J R Soc Med 89 Suppl 27 38-43.
146. P Maisonneuve, et al. (2003) Cancer risk in nontransplanted and transplanted cystic fibrosis patients: A 10-year study. J Natl Cancer Inst 95 381-387.
147. RA Padua, et al. (1997) The cystic fibrosis delta F508 gene mutation and cancer. Hum Mutat 10 45-48.
148. MW Konstan, et al. (2003) Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 142 624-630.
149. LT Beker, et al. (2001) Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc 101 438-442.
150. DS Hardin (2002) Growth problems and growth hormone treatment in children with cystic fibrosis. J Pediatr Endocrinol Metab 15 Suppl 2 731-735.
151. DS Hardin, et al. (2001) Growth hormone improves clinical status in prepubertal children with cystic fibrosis: Results of a randomized controlled trial. J Pediatr 139 636-642.
152. DS Hardin, et al. (2005) Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition. J Pediatr 146 324-328.
153. A Schibler, et al. (2003) Prospective randomised treatment with recombinant human growth hormone in cystic fibrosis. Arch Dis Child 88 1078-1081.
154. AS Brody, et al. (2004) High-resolution computed tomography in young patients with cystic fibrosis: Distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 145 32-38.
155. AS Brody, et al. (2005) Computed tomography in the evaluation of cystic fibrosis lung disease. Am J Respir Crit Care Med 172 1246-1252.
156. PA de Jong, et al. (2006) Estimation of cancer mortality associated with repetitive computed tomography scanning. Am J Respir Crit Care Med 173 199-203.
157. RP Baughman, et al. (1997) Use of bronchoalveolar lavage semiquantitative cultures in cystic fibrosis. Am J Respir Crit Care Med 156 286-291.
158. SD Aaron, et al. (2004) Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis. Eur Respir J 24 631-637.
159. A Jung, et al. (2002) Genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patients. Eur Respir J 20 1457-1463.